EISAI R&D MANAGEMENT CO., LTD.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 23871
 
  
 
C07D HETEROCYCLIC COMPOUNDS 21133
 
  
 
C07K PEPTIDES 32104
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 30176
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 2743
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 27140
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 2798
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 26112
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 2273
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1881

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0071,247 COMBINATION OF A PD-1 ANTAGONIST AND ERIBULIN FOR TREATING CANCERMar 03, 16Mar 15, 18[A61K, C07K]
2018/0044,711 LYSINE CONJUGATED IMMUNOGLOBULINSJul 28, 17Feb 15, 18[A61K, C12P, C07K]
2018/0028,662 Method for Suppressing Bitterness of Quinoline DerivativeFeb 23, 16Feb 01, 18[A61K]
2018/0024,150 BIOMARKER OF DEMENTIA WITH LEWY BODIESMar 04, 16Jan 25, 18[G01N]
2018/0015,079 THERAPEUTIC AGENT FOR BILE DUCT CANCERMar 23, 16Jan 18, 18[A61K]
2017/0360,797 METHOD FOR TREATING CANCERNov 17, 15Dec 21, 17[A61K]
2017/0191,137 Method For Predicting Effectiveness Of Angiogenesis InhibitorMar 16, 17Jul 06, 17[A61K, C12Q, G01N]
2017/0182,003 COMBINATION THERAPIES FOR THE TREATMENT OF CANCERMay 21, 15Jun 29, 17[A61K]
2017/0100,367 USE OF ERIBULIN IN THE TREATMENT OF CANCERMay 27, 15Apr 13, 17[A61K]
2017/0071,903 USE OF ERIBULIN AND MTOR INHIBITORS AS COMBINATION THERAPY FOR THE TREATMENT OF CANCERMar 02, 15Mar 16, 17[A61K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9872862 Salt form of a human histone methyltransferase EZH2 inhibitorJun 30, 16Jan 23, 18[A61K]
9873669 Cationic lipidJan 07, 15Jan 23, 18[A61K, C07D, C12N]
9856276 Compounds useful in the synthesis of halichondrin B analogsJun 29, 16Jan 02, 18[C07F, C07D]
9850242 Tetrahydropyrazolopyrimidine compoundsAug 10, 16Dec 26, 17[A61K, A01N, C07D]
9828336 Methods and compounds useful in the synthesis of orexin-2 receptor antagonistsMay 19, 16Nov 28, 17[C12P, C07D, C07C]
9809647 Neutralizing anti-CCL20 antibodiesAug 03, 15Nov 07, 17[A61K, G01N, C07K]
9802953 Intermediates and methods for the synthesis of halichondrin B analogsApr 07, 16Oct 31, 17[C07D]
9796683 Tetrasubstituted alkene compounds and their useMay 27, 16Oct 24, 17[A61K, A01N, C07D]
9783549 Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin BNov 04, 14Oct 10, 17[C07F, C07D]
9784751 Method for detecting neurological disease associated with cognitive impairment by measuring EphA4 extracellular domainApr 25, 12Oct 10, 17[C12N, G01N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0326,161 SELECTIVELY SUBSTITUTED QUINOLINE COMPOUNDSAbandonedJul 27, 16Nov 10, 16[C12Q, C07D, G01N]
2016/0089,365 IMMUNOSTIMULATORY COMPOUNDAbandonedSep 23, 15Mar 31, 16[A61K]
2016/0052,937 Tetrahydroimidazo[1,5-d][1,4]oxazepine compoundAbandonedAug 20, 15Feb 25, 16[C07D]
2016/0045,625 [11C] AND [18F] LABELED 1,3-DIPHENYL-5-(PYRIMIDIN-2-YL)-PYRIDIN-2(1H)-ONE DERIVATIVES AND THEIR USE FOR PET IMAGING OF THE AMPA RECEPTORAbandonedApr 02, 14Feb 18, 16[A61K, C07D]
2015/0299,788 RNA DETECTION METHOD AND DETECTION KITAbandonedMay 13, 13Oct 22, 15[C12Q]
9029573 Halichondrin B analogsWithdrawnOct 21, 13May 12, 15[C07D]
2014/0349,879 METHOD FOR DETECTING NUCLEOTIDE MUTATION, AND DETECTION KITAbandonedDec 07, 12Nov 27, 14[C12Q]
2014/0163,095 USE OF ERIBULIN IN THE TREATMENT OF BREAST CANCERAbandonedDec 04, 13Jun 12, 14[A61K]
2014/0148,483 Method For Predicting Effectiveness Of Angiogenesis InhibitorAbandonedMay 16, 12May 29, 14[A61K, C12Q]
2014/0099,366 Composition Containing Two Anti-Dementia DrugsAbandonedDec 13, 13Apr 10, 14[A61K]
2014/0065,100 Compositions and Methods for Cancer ImmunotherapyAbandonedNov 08, 13Mar 06, 14[A61K]
8658620 Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseasesExpiredJan 09, 09Feb 25, 14[A61K, A01N]
2013/0296,352 PYRAZOLOQUINOLINE DERIVATIVESAbandonedJun 11, 13Nov 07, 13[C07D]
2013/0296,365 QUINOLINE DERIVATIVE-CONTAINING PHARMACEUTICAL COMPOSITIONAbandonedJun 21, 13Nov 07, 13[A61K]
2013/0288,956 COMBINED PHARMACEUTICAL COMPOSITION AS ANTIFUNGAL AGENTAbandonedNov 04, 11Oct 31, 13[A61K]
8530504 Pyrazolothiazole compoundExpiredOct 07, 10Sep 10, 13[A61K, A61P]
2013/0211,103 INTERMEDIATES AND METHODS FOR MAKING ZEARALENONE MACROLIDE ANALOGSAbandonedJan 03, 13Aug 15, 13[C07D]
8501733 Spiroaminodihydrothiazine derivativesExpiredJul 24, 09Aug 06, 13[A61K, C07D]
2013/0189,360 COMPRESSED COMPOSITIONAbandonedAug 03, 11Jul 25, 13[A61K]
8450058 Method of detecting target substanceExpiredAug 11, 08May 28, 13[C07H, C12Q]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.